The enhanced efficacy of NAC/PPT on neuropathic pain and ALS compared with NAC alone suggests that PEG-PCL-Tat facilitates better absorption and transport of NAC from the nasal cavity to the central nervous system, potentially leading to increased bioavailability in the spinal cord. This evidence concerns the gene TAT and amyotrophic lateral sclerosis.